医療用食品の世界市場規模：医療用食品タイプ別、用途分野別、流通チャネル別、地域別、範囲および予測

医療用食品の市場規模と予測

医療用食品の市場規模は2024年に189億6,000万米ドルと評価され、2031年には330億5,000万米ドルに達すると予測され、2024年から2031年までのCAGRは7.19%で成長します。医療用食品は、医師の指示のもと食事を通じて特定の医学的障害をコントロールするために設計された特殊な処方です。通常の食品や栄養補助食品とは異なり、代謝障害、吸収不良症候群、慢性疾患を患う人々の栄養ニーズを満たすよう特別に設計されています。その製剤は、通常の食事だけでは管理できない特定の栄養欠乏や代謝の不均衡に対処するよう、科学的に設計されています。

実際、医療用食品は、通常の治療を特殊な栄養で補うという重要な役割を担っています。医療用食品は、フェニルケトン尿症（PKU）、糖尿病性神経障害、炎症性腸疾患など、疾病管理と患者の健康のために食生活の改善を必要とする疾患の治療に用いられています。医療用食品は、必要な栄養素または基質を正確に供給することによって、治療介入を支援し、治療コンプライアンスを向上させ、患者の転帰を改善します。

栄養科学とオーダーメイド医療の継続的な進歩により、薬用食品の将来は明るいと思われます。食事と健康との間の複雑な関係が調査によって明らかになるにつれて、薬用食品はより正確な処方で進化し、より広範な疾病に適用できるようになると予想されます。個別化された治療計画での使用や予防医療への注目の高まりによって、薬用食品の普及が加速し、ヘルスケア環境における栄養管理の方法が変わる可能性があります。

医療用食品の市場力学

世界の医療用食品市場を形成している主な市場力学

主な市場促進要因：

慢性疾患の有病率の増加：

糖尿病、心血管疾患、代謝異常などの慢性疾患が世界的に蔓延するにつれて、医療用食品のような特定の食餌療法に対する需要が高まっています。こうした食品は、独自の食事療法を必要とする人々の症状管理を支援し、健康状態の改善と生活の質の向上をもたらします。

ヘルスケアと栄養科学の進歩：

医療食品のイノベーションは、ヘルスケアおよび栄養科学における継続的な研究開発によって推進されます。これには、疾病の原因、食事の必要条件、製剤技術に関するより深い理解が含まれ、その結果、患者固有の需要に対応する、より効果的で的を絞った医薬品が生み出されます。

支持的な規制環境：

薬用食品を従来の食品や栄養補助食品と区別する規制の枠組みは、明確性をもたらし、業界の拡大を促進します。明確なガイドラインは、市場参入を可能にすると同時に、安全性と有効性を確保する製品開発とラベリングおよびマーケティングにおいて生産者を支援します。

主要課題：

規制の複雑さ：

最も困難な問題のひとつは、複雑な規制の枠組みの交渉です。医療用食品は、地域によって異なる独自の規制要件を満たさなければならないため、製造業者が市場許可を取得し、多様な規制基準への準拠を保証することが困難となります。この複雑さは、製品上市の遅延や規制当局の承認費用の増加を引き起こす可能性があります。

マーケティング教育と意識向上：

ヘルスケア担当者、患者および介護者は、医療用食品の意義と利点に対する認識が不足していることが多いです。効果的なコミュニケーションと教育は、受容と採用の獲得に不可欠です。医療従事者の多くは、薬用食品、栄養補助食品、および通常の食品の違いを十分に理解していない可能性があり、これが処方の手順や患者のコンプライアンスに影響を及ぼす可能性があります。

コストと償還の問題

：医療用食品は、多くの国々では健康保険が適用されたり公的医療制度を通じて償還されたりすることはほとんどないです。このような償還の欠如は、患者の自己負担額が人によっては法外に高額になる可能性があるため、患者のアクセスの障害となりうる。さらに、薬用食品は通常の食品や栄養補助食品に比べて高価であると認識されているため、ヘルスケアに携わる人々や患者は、薬用食品を実行可能な治療選択肢として考慮することを躊躇してしまう可能性があります。

主要動向：

個別化された栄養：

遺伝学とメタボロミクスの進歩が、個別化栄養への推進に拍車をかけています。医療食は、遺伝学、ライフスタイル、および健康上の問題に基づき、個々の栄養要求を満たすように設計されるようになってきています。この精密なアプローチは、個別化された栄養サポートを提供することで、有効性と患者の転帰を改善しようとするものです。

技術革新：

製品開発と流通に新技術を取り入れることで、医療食品業界は変貌を遂げています。医療食は、バイオアベイラビリティの進歩、経腸栄養デバイスなどの新しいデリバリー技術、患者のアドヒアランスや反応をモニタリングするためのデジタルヘルスツールなどにより、ますます効果的で使い勝手の良いものになってきています。こうした改善は、患者の体験と転帰の改善に役立っています。

慢性疾患管理の重視：

慢性疾患管理のための包括的ケア方法に薬用食品を取り入れることが重視されるようになってきています。糖尿病、アルツハイマー病、および胃腸疾患は現在、特定の代謝経路や栄養欠損をターゲットとする医療用食品によって治療されています。こうした傾向は、予防医療や、医学的治療と栄養療法を混合した統合的治療技術への、より広範なシフトを示しています。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 医療用食品市場：医療用食品タイプ別

• 栄養完全食品
• 栄養的に不完全な食品

第5章 医療用食品市場：用途分野別

• 代謝障害
• 胃腸障害
• 神経疾患
• 腎臓疾患
• 腫瘍学

第6章 医療用食品市場：流通チャネル別

• 薬局・ドラッグストア
• 病院・診療所
• オンライン小売

第7章 地域分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Danone
• Nestle
• Abbott
• Fresenius Kabi
• Targeted Medical Pharma Inc.
• Primus Pharmaceuticals Inc.
• Mead Johnson & Company LLC

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Medical Foods Market Size And Forecast

Medical Foods Market size was valued at USD 18.96 Billion in 2024 and is projected to reach USD 33.05 Billion by 2031 , growing at a CAGR of 7.19% from 2024 to 2031. Medical foods are specialized formulas designed to control specific medical disorders through diet under the direction of a physician. Unlike normal foods or dietary supplements, they are specifically designed to fulfill the nutritional needs of people suffering from metabolic disorders, malabsorption syndromes or chronic diseases. Their formulations are scientifically designed to address specific nutritional deficiencies or metabolic imbalances that cannot be managed with a normal diet alone.

In practice, medical foods serve an important role in supplementing normal medical treatments with specialized nutrition. They are used to treat illnesses such as phenylketonuria (PKU), diabetic neuropathy and inflammatory bowel disease which require dietary changes for disease management and patient health. Medical foods assist therapeutic interventions, increase treatment compliance and improve patient outcomes by precisely delivering the required nutrients or substrates.

The future of medicinal foods seems hopeful due to continued advances in nutrition science and customized medicine. As research reveals more about the complex relationship between diet and health, medicinal foods are expected to evolve with more accurate formulations and increased applicability across a larger spectrum of illnesses. Their use in personalized treatment plans and the growing focus on preventative health care may speed up their spread which could change how nutrition is managed in healthcare settings.

Medical Foods Market Dynamics

The key market dynamics that are shaping the global medical foods market include:

Key Market Drivers:

Increasing Prevalence of Chronic Diseases:

As chronic ailments such as diabetes, cardiovascular disease and metabolic disorders become more prevalent worldwide, there is a growing demand for specific dietary therapies such as medical foods. These items assist individuals with unique dietary needs in managing symptoms improving health outcomes and improving their quality of life.

Advancements in Healthcare and Nutrition Science:

Medical food innovation is driven by ongoing research and development in healthcare and nutrition science. This involves a greater understanding of disease causes, dietary requirements and formulation technologies resulting in more effective and targeted medicines that address patient's unique demands.

Supportive Regulatory Environment:

Regulatory frameworks that distinguish medicinal foods from conventional foods and dietary supplements provide clarity and promote industry expansion. Clear guidelines assist producers with product development labeling and marketing ensuring safety and efficacy while enabling market access.

Key Challenges:

Regulatory Complexity:

One of the most difficult problems is negotiating the complex regulatory framework. Medical foods must meet unique regulatory requirements that differ by area making it difficult for manufacturers to obtain market permission and assure compliance with varied regulatory standards. This intricacy might cause product launch delays and increase regulatory approval expenses.

Marketing Education and Awareness:

Healthcare personnel, patients and caregivers frequently lack awareness of the significance and benefits of medical foods. Effective communication and education are critical for attaining acceptance and adoption. Many healthcare practitioners may not fully comprehend the differences between medicinal foods, dietary supplements and regular foods which can impact prescribing procedures and patient compliance.

Costs and Reimbursement Issues

: Medical foods are rarely covered by health insurance or reimbursed through public healthcare systems in many countries. This lack of reimbursement can be a barrier to patient access as out-of-pocket expenditures may be prohibitively expensive for some people. Furthermore, the perceived high cost of medicinal foods compared to ordinary foods or dietary supplements may discourage healthcare practitioners and patients from considering them as a viable therapeutic choice.

Key Trends:

Personalized Nutrition:

Advances in genetics and metabolomics are fueling the push toward individualized nutrition. Medical meals are increasingly being designed to satisfy individual nutritional demands based on genetics, lifestyle and health problems. This precision approach attempts to improve efficacy and patient outcomes by offering personalized nutritional support.

Technological Innovation:

The incorporation of new technology into product development and distribution is transforming the medical food industry. Medical meals are becoming increasingly effective and user-friendly due to advancements in bioavailability, novel delivery techniques (such as enteral feeding devices) and digital health tools for monitoring patient adherence and reaction. These improvements help to improve patient experiences and outcomes.

Focus on Chronic Disease Management:

There is a rising emphasis on incorporating medicinal foods into comprehensive care methods for chronic illness management. Diabetes, Alzheimer's disease and gastrointestinal diseases are now being treated with medical foods that target specific metabolic pathways and nutritional deficits. This tendency is indicative of a broader shift toward preventative healthcare and integrated treatment techniques that mix medical and nutritional therapy.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Medical Foods Market Regional Analysis

Here is a more detailed regional analysis of the global medical foods market:

North America:

According to Verified Market Research analyst, North America is expected to dominate the global medical foods market.

North America dominates the medical food market for a variety of reasons. The region has a high frequency of chronic diseases such as diabetes, cardiovascular disease and metabolic disorders which increases the demand for specialist nutritional treatments. North America's advanced healthcare system encourages the widespread use of medicinal foods with healthcare providers increasingly acknowledging their importance in illness treatment and patient care. Furthermore, the presence of major pharmaceutical and biotechnology companies in the region enables significant investment in R&D resulting in breakthrough medical food products adapted to specific patient needs.

Furthermore, North America's regulatory framework particularly in the United States, supports the expansion of the medical food industry. The Food and Drug Administration (FDA) has established clear rules and a structured regulatory framework for the approval and marketing of medical foods ensuring product safety and efficacy. This regulatory certainty stimulates producers to create and launch innovative goods. Furthermore, increased consumer and healthcare professional knowledge of medicinal food benefits aided by effective marketing and educational programs contributes to the region's market dominance.

Asia Pacific:

Asia Pacific is the fastest-growing region in the medical foods market due to several critical factors. The prevalence of chronic diseases in the region such as diabetes, cardiovascular problems and malnutrition-related conditions are rapidly increasing. This spike is driving up demand for effective nutritional therapies establishing medicinal foods as critical components of comprehensive disease management plans. The growing middle class and disposable incomes also allow for more access to specialty healthcare items which boosts market growth.

Governments and the business sector are investing extensively in healthcare facilities, research and development resulting in improved diagnosis and treatment of chronic diseases. This development involves increased knowledge of the importance of medical nutrition which promotes the use of medical foods. The significant aging population in countries such as Japan and China contributes to a growing demand for medical foods specifically designed to address age-related health conditions.

Furthermore, the regulatory climate in Asia and the Pacific is becoming increasingly friendly to the medical food industry. Countries in the region are implementing clearer regulatory frameworks to facilitate the creation approval and marketing of medical foods. This governmental assistance together with increased collaborations between local and foreign enterprises promotes innovation and speeds up the introduction of new products to the market. As healthcare professionals and consumers become more aware of the benefits of medicinal foods, the Asia-Pacific region's market will continue to rise rapidly.

Global Medical Foods Market: Segmentation Analysis

The Global Medical Foods Market is segmented on the basis of Type of Medical Foods, Application Areas, Distribution Channels and Geography.

Medical Foods Market, By Type of Medical Foods

• Nutritionally Complete Foods
• Nutritionally Incomplete Foods

Based on Type of Medical Foods, the market is Nutritionally Complete Foods and Nutritionally Incomplete Foods. Nutritionally complete foods dominate the medical food market because they contain all of the important nutrients needed for everyday health making them excellent for patients with severe diseases or those who cannot consume ordinary diets. These solutions provide full nutritional assistance ensuring that patients meet their dietary demands efficiently which is critical for treating chronic diseases and recovering from serious health issues resulting in increased demand and market dominance.

Medical Foods Market, By Application Areas

• Metabolic Disorders
• Gastrointestinal Disorders
• Neurological Disorders
• Renal Disorders
• Oncology

Based on Application Areas, the market is divided into Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, Renal Disorders and Oncology. Metabolic disorders dominate the market due to the high prevalence and complexity of conditions such as diabetes and phenylketonuria (PKU). These disorders often require precise dietary management that cannot be achieved through conventional diets alone. Medical foods tailored for metabolic disorders provide important and essential nutrients and help manage metabolic imbalances making them crucial for patient health and driving their leading position in the market.

Medical Foods Market, By Distribution Channels

• Pharmacies and Drug Stores
• Hospitals and Clinics
• Online Retail

Based on Distribution Channels, the market is segmented into Pharmacies and Drug Stores, Hospitals and Clinics, Online Retail. Pharmacies and drug stores dominate the medical foods market because of their ubiquitous accessibility and consumer confidence. These channels provide convenience for people who require regular refills and professional advice from pharmacists. Furthermore, the existing infrastructure and good contacts with healthcare experts ease the distribution and recommendation of medicinal foods making pharmacies and drug stores the preferred source for these specialized nutritional products.

Medical Foods Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Medical Foods Market is classified into North America, Europe, Asia Pacific and the Rest of the world. North America leads the medical foods market because of a high prevalence of chronic diseases an advanced healthcare system and significant R&D expenditure by large pharmaceutical and biotech businesses. The FDA's clear regulatory framework promotes product safety and efficacy fostering innovation and market expansion. Meanwhile, Asia Pacific is the fastest-growing market owing to rising chronic diseases, greater healthcare spending, a growing middle class and favorable regulatory regimes that encourage innovation and product adoption.

Key Players

• The Global Medical Foods study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Danone, Nestle, Abbott, Fresenius Kabi, Targeted Medical Pharma Inc., Primus Pharmaceuticals Inc. and Mead Johnson & Company LLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

• Medical Foods Market Recent Developments
• In March 2022, Lanfam LLC introduced Proleeva, a unique medicinal food designed to alleviate chronic pain in conditions like fibromyalgia, osteoporosis, diabetic neuropathy and rheumatoid arthritis. The company also offers tailored solutions for specific conditions, allowing it to be identified as an innovator in the market.
• In December 2021, SFI Health launched two new medical foods, EQUAZEN PRO and Ther-Biotic PRO IBS Relief, to treat irritable bowel syndrome (IBS) and improve dietary nutrition. These developments have strengthened the company's market position as a significant innovator.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Medical Foods Market, By Type of Medical Foods

• Nutritionally Complete Foods
• Nutritionally Incomplete Foods

5. Medical Foods Market, By Application Areas

• Metabolic Disorders
• Gastrointestinal Disorders
• Neurological Disorders
• Renal Disorders
• Oncology

6. Medical Foods Market, By Distribution Channels

• Pharmacies and Drug Stores
• Hospitals and Clinics
• Online Retail

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Danone
• Nestle
• Abbott
• Fresenius Kabi
• Targeted Medical Pharma Inc.
• Primus Pharmaceuticals Inc.
• Mead Johnson & Company LLC

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References